Abhishek Shankar, Associate Professor of the Department of Radiation Oncology at All India Institute of Medical Sciences, shared a post on LinkedIn by Devex, adding:
“This is an important public health consideration.
Those who are eligible for lung cancer screening are encouraged to go for it.
Kindly email me at doc.abhishankar@gmail.com to get it done at AIIMS, Delhi or any part of the country under the Indian lung screening trial, funded by the Bristol Myers Squibb Foundation.”
Quoting Devex:
“Lung cancer screening guidelines have largely been shaped by smoking history. But in India, where an estimated 40% to 50% of people living with lung cancer are never-smokers, does that approach capture everyone who may be at risk?
In a new Devex-sponsored opinion piece, Catharine Grimes, president of the Bristol Myers Squibb Foundation (BMS Foundation), and Dr. Abhishek Shankar, radiation oncologist at the All India Institute of Medical Sciences (AIIMS), explore how two new trials in India are building locally grounded evidence around lung cancer risk and screening.
The AIRCARE initiative is examining the role of air pollution, including PM2.5 exposure, alongside behavioral, clinical, and genetic risk factors. In parallel, the Indian Lung Screening Trial is evaluating how low-dose CT screening could work within India’s health system.
Read the full opinion piece.”
Other articles featuring Abhishek Shankar on OncoDaily.